Perceptive Advisors LLC Poseida Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

  • $3.83 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$2.43 - $4.51 $1.82 Million - $3.38 Million
750,000 New
750,000 $2.65 Million
Q4 2021

Feb 14, 2022
SELL
$6.23 - $7.6 $4.91 Million - $5.99 Million
-787,745 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$8.09 - $16.25 $6.37 Million - $12.8 Million
787,745 New
787,745 $6.99 Million

Others Institutions Holding PSTX

# of Institutions
98
Shares Held
38.5M
Call Options Held
377K
Put Options Held
22.2K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $810M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email